BioMedGPS announces expanded coverage of SmartTRAK Business Intelligence for the Surgical Wound Market with the addition of its newest module, US Hemostats & Sealants.
SmartTRAK’s US Market for Hemostats and Sealants module covers the $1.2B market for thrombin hemostats, absorbable hemostats, fibrin sealants, synthetic sealants and biologic sealants used in surgical applications. BioMedGPS estimates the market will grow to $1.6B in 2021E, a CAGR of over 7%. The module provides real time, up-to-date market data, including 5-year market and procedural projections, quarterly revenue tracking, competitive overviews, clinical and regulatory activities and much more.
